COBRRA Trial Results Raise Questions About VTE Management
The COBBRA trial compared bleeding risk with rivaroxaban versus apixaban in patients with acute venous thromboembolism.
Type 2 Diabetes and Obesity in Teens Could Increase Risk of Osteoporosis
Obesity and type 2 diabetes in youth significantly increase the risk of osteoporosis and fractures, highlighting the need for early…
Vaccination Can Reduce Long-Term Kidney Function Decline, Mortality Risk in Hospitalized Patients With COVID-19
Receiving a COVID-19 vaccination vastly reduced the risk of long-term hospitalization, necessitating dialysis, and morbidity in patients hospitalized with acute…
Insulin Aspart-xjhz Becomes First Interchangeable Biosimilar Rapid-Acting Insulin
The agent, Kirsty, represents a more affordable alternative to Novolog.
Pharmacists Address Thimerosal’s Role, Safety, and ACIP’s Updated Flu Vaccine Recommendation
Adam James, PharmD, and Chris Altman, PharmD, discuss renewed public scrutiny of thimerosal, its limited use in vaccines today, and…
Large Real-World Study Validates Idecabtagene Vicleucel Outcomes Seen in KarMMa Trial
The data showed patients with relapsed or refractory multiple myeloma achieved a 73% overall response rate.
Study: Recommendations From Health Care Professionals Improve Immunization Rates Among Patients With CKD
Patients with chronic kidney disease (CKD) were more likely to get vaccinated for influenza and pneumococcal following a health care…
Finerenone and the Future of Diabetes-Related Kidney Care
Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
